Emtricitabine is a potent nucleoside reverse transcriptase inhibitor (NRTI) effective against HIV and HBV, demonstrating an EC50 of 0.01 µM in PBMC assays. It is widely used in both in vitro virology studies and in vivo models to investigate antiviral mechanisms and therapeutic strategies for retroviral infections.